NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control

CompletedN/A

Sponsor: Fundación Pública Andaluza Progreso y Salud

Conditions: Healthy Subjects

Countries: Austria, Belgium, France, Germany, Hungary, Italy, Portugal, Spain

Connective tissue diseases (CTD) or systemic autoimmune diseases (SADs) as they are known today are a group of chronic inflammatory conditions with autoimmune aetiology with few treatment options and difficult diagnosis.Brest team contribute to perform a new classification of the following systemic autoimmune diseases in a European Union's Seventh Framework Programme. The aim of this research is to constitute a Healthy Volunteers cohort to compare with systemic autoimmune diseases cohort into molecular clusters instead of clinical entities through the determination of molecular profiles using several "Omics" techniques.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Aged 18 years or older at the time of consent
* Signed the informed consent form

Exclusion Criteria:

* Individuals on chronic medication.
* Individuals suffering from any inflammatory, autoimmune, allergic or infectious condition and if possible without a history of autoimmune disease, particularly thyroid disease or other diseases that may modify cellular profiles in blood.
* Pregnant women.

Locations (17)

Vienna, Austria
Leuven, Belgium
Brest, France
Berlin, Germany
Hanover, Germany
Szeged, Hungary
Milan, Italy
Milan, Italy
Porto, Portugal
Barcelona, Spain
Córdoba, Spain
Granada, Spain
Granada, Spain
Granada, Spain
Málaga, Spain
Santander, Spain
Geneva, Switzerland